• Explore /
  • Poster
  • / Expression of p16, ERCC,1 and EGFR amplification as predictors of responsiveness of locally advanced squamous cell carcinomas of head and neck (SCCHN) to cisplatin, radiotherapy, and erlotinib: A phase II randomized trial.

Expression of p16, ERCC,1 and EGFR amplification as predictors of responsiveness of locally advanced squamous cell carcinomas of head and neck (SCCHN) to cisplatin, radiotherapy, and erlotinib: A phase II randomized trial.

Abstract Poster

Authors

null

Melissa Austin

University of Washington, Seattle, WA

Melissa Austin , Rodney Schmidt , Upendra Parvathaneni , Julie E. Bauman , David N. Hayes , Michael A. Papagikos , Keith D. Eaton , Jay Justin Liao , Eduardo Mendez , Brenda F Kurland , Shawn Xiaoyu , Sarah G. Wallace , Renato Martins

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2012 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Head and Neck Cancer

Clinical Trial Registration Number

NCT00410826

Citation

J Clin Oncol 30, 2012 (suppl; abstr 5515)

DOI

10.1200/jco.2012.30.15_suppl.5515

Abstract #

5515

Poster Bd #

5

Abstract Disclosures

Similar Posters

First Author: Ligang Xing

First Author: Margaret Winn Kendrick

First Author: Thiago Bueno Oliveira Sr.

First Author: Markus Hecht